Reactive arthritis secondary to Hafnia alvei enterocolitis
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ..
Diagnosis of postenteritic reactive arthritis (ReA) is a challenge and might have a broad range of differential diagnoses. A 50-year-old man was referred to our attention because of persistent inflammatory low back pain and asymmetric oligoarthritis. The clinical history was positive for diarrhoea in the previous 3 months. Inflammatory bowel disease, Whipple and celiac diseases were carefully excluded. In addition, serology, stool cultures, biopsies from the upper gastrointestinal tract yielded negative results for infections. A presumptive diagnosis of ReA was done and a non-steroidal anti-inflammatory drug trial prescribed. Persistence of symptoms prompted us for a second look of the colon. Biopsy collected from the terminal ileum were cultured and surprisingly colonies of Hafnia alvei, a rod-shaped Enterobacteriaceae, were detected. Treatment with ciprofloxacin leads to fast symptoms resolution. Although enterocolitis from H. alvei has been rarely reported, the culture of intestinal specimens might be recommended in the work-up of patients with suspected postenteritic ReA.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
BMJ case reports - 12(2019), 5 vom: 28. Mai |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Erre, Gian Luca [VerfasserIn] |
---|
Links: |
---|
Themen: |
5E8K9I0O4U |
---|
Anmerkungen: |
Date Completed 16.12.2019 Date Revised 04.12.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/bcr-2018-228513 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM297603531 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM297603531 | ||
003 | DE-627 | ||
005 | 20231225092339.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bcr-2018-228513 |2 doi | |
028 | 5 | 2 | |a pubmed24n0991.xml |
035 | |a (DE-627)NLM297603531 | ||
035 | |a (NLM)31142484 | ||
035 | |a (PII)e228513 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Erre, Gian Luca |e verfasserin |4 aut | |
245 | 1 | 0 | |a Reactive arthritis secondary to Hafnia alvei enterocolitis |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2019 | ||
500 | |a Date Revised 04.12.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a Diagnosis of postenteritic reactive arthritis (ReA) is a challenge and might have a broad range of differential diagnoses. A 50-year-old man was referred to our attention because of persistent inflammatory low back pain and asymmetric oligoarthritis. The clinical history was positive for diarrhoea in the previous 3 months. Inflammatory bowel disease, Whipple and celiac diseases were carefully excluded. In addition, serology, stool cultures, biopsies from the upper gastrointestinal tract yielded negative results for infections. A presumptive diagnosis of ReA was done and a non-steroidal anti-inflammatory drug trial prescribed. Persistence of symptoms prompted us for a second look of the colon. Biopsy collected from the terminal ileum were cultured and surprisingly colonies of Hafnia alvei, a rod-shaped Enterobacteriaceae, were detected. Treatment with ciprofloxacin leads to fast symptoms resolution. Although enterocolitis from H. alvei has been rarely reported, the culture of intestinal specimens might be recommended in the work-up of patients with suspected postenteritic ReA | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a infectious diseases | |
650 | 4 | |a rheumatology | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a PHB2 protein, human |2 NLM | |
650 | 7 | |a Prohibitins |2 NLM | |
650 | 7 | |a Ciprofloxacin |2 NLM | |
650 | 7 | |a 5E8K9I0O4U |2 NLM | |
700 | 1 | |a Colombo, Enrico |e verfasserin |4 aut | |
700 | 1 | |a Bibbò, Stefano |e verfasserin |4 aut | |
700 | 1 | |a Dore, Maria Pina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ case reports |d 2008 |g 12(2019), 5 vom: 28. Mai |w (DE-627)NLM209291001 |x 1757-790X |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2019 |g number:5 |g day:28 |g month:05 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bcr-2018-228513 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2019 |e 5 |b 28 |c 05 |